Ország: Izrael
Nyelv: angol
Forrás: Ministry of Health
BOSENTAN AS MONOHYDRATE
RAFA LABORATORIES LTD
C02KX01
TABLETS
BOSENTAN AS MONOHYDRATE 62.5 MG
PER OS
Required
GENVION CORPORATION, CANADA
BOSENTAN
Treatment of pulmonary arterial hypertension (PAH) in patients of WHO functional class II-IV. Reduction in the number of new digital ulcers in patients with systemic sclerosis with active digital ulcer disease
2021-09-30
PATIENT LEAFLET ACCORDING TO THE PHARMACISTS' REGULATIONS (PREPARATIONS) - 1986 This medicine is sold with a doctor's prescription only TRASENTAN 62.5 TRASENTAN 125 TABLETS ACTIVE INGREDIENT: TRASENTAN 62.5: Each tablet contains Bosentan monohydrate equivalent to 62.5 mg of Bosentan. TRASENTAN 125: Each tablet contains Bosentan monohydrate equivalent to 125 mg of Bosentan. For a list of the other ingredients, please see section 6. READ THIS ENTIRE LEAFLET CAREFULLY BEFORE USING THIS MEDICINE. This leaflet contains concise information about the medicine. If you have any further questions, refer to the doctor or pharmacist. This medicine has been prescribed for treating your illness. Do not pass it on to others. It may harm them, even if it seems to you that their illness is similar to yours. Patient safety information card In addition to the leaflet, Trasentan has a patient safety information card concerning potential harm to an unborn baby (fetus). This card contains important safety information that you should know before starting and during the treatment. Read the patient safety information card and the patient leaflet before using this medicine. Keep the card and leaflet so you can read it again if you need to. Do not take Trasentan if you are pregnant because using this medicine may harm the fetus (see Section 2 'Before using this medicine' under the subsections 'Do not use this medicine if' and 'Fertility, pregnancy and breastfeeding'). If you are a woman of childbearing age and it is possible for you to get pregnant, perform a pregnancy test before starting treatment with Trasentan and routinely every month while taking this medicine, as well as a month after completing the treatment. Confirm each time that the pregnancy test result is negative. You must use a reliable contraceptive to prevent pregnancy while you are taking Trasentan, and for one more month after completing your treatment (see section 2 'Fertility, pregnancy and breastfeeding'). 1. WHAT IS THE MEDICINE INTENDED FOR? • To treat pulmonary a Olvassa el a teljes dokumentumot